noom and glp-1 to offer drug through new weight loss program Noom GLP-1rx Program — Prescription

10.1038/s41575-018-0082-x 38 KennyP

This license permits unrestricted use, distribution, and reproduction in any medium, including commercial use, provided the original author(s) and source are properly credited

However, with stronger glucagon receptor stimulation, it would be important for further pre-clinical studies to characterise the effects of lead drug candidates, on plasma amino acids and lean mass

Agencia Canaria de Investigacin, Innovacin y Sociedad de la Informacin (ACIISI) del Gobierno de Canarias, project ProID2020010134, Caja Canarias, Project 2019SP43, the State Plan for Scientific, Technical Research and Innovation 20212023 from the Spanish Ministry of Science and Innovation (project PLEC2022-009507) and Spanish Ministry of Economy and Competitiveness (Grant PID2019-105838RB-C31)